BFM
COLL icon

Boothbay Fund Management’s Collegium Pharmaceutical COLL Stock Holding History

Boothbay Fund Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,490
Closed -$289K – 1548
2024
Q3 		$289K Buy
+7,490
New +$267K 0.01% 1271
2022
Q2 		– Sell
-15,085
Closed -$307K – 2314
2022
Q1 		$307K Buy
+15,085
New +$285K 0.01% 1597
2019
Q2 		– Sell
-52,804
Closed -$799K – 760
2019
Q1 		$799K Buy
+52,804
New +$846K 0.08% 280
2018
Q2 		– Sell
-15,750
Closed -$402K – 762
2018
Q1 		$402K Buy
+15,750
New +$375K 0.05% 383

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Boothbay Fund Management's COLL Position: Q4 2024 in Review

Boothbay Fund Management sold out of Collegium Pharmaceutical (COLL) in Q4 2024, closing a stake of 7,490 shares — an estimated $289K sold.

Boothbay Fund Management first reported a position in COLL in Q1 2018 and held it in 4 quarters. The position peaked at $799K in Q1 2019. 238 funds tracked by Wall St. Rank hold COLL as of Q4 2024.

  • Boothbay Fund Management reported no remaining Collegium Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 7,490 Collegium Pharmaceutical shares in Q4 2024, an estimated $289K.
  • Boothbay Fund Management first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 4 quarters.
  • Boothbay Fund Management's Collegium Pharmaceutical position peaked at $799K in Q1 2019.
  • 238 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.